查找临床试验
已按「黑色素瘤」检索，对应国际通用词 melanoma
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 11:18，每 5 分钟自动同步正在招募II 期中国有中心NCT07310784
A Phase II Trial of LM103 in Advanced Melanoma
China
年龄 18 Years – 75 Years
Suzhou BlueHorse Therapeutics Co., Ltd.
正在招募II 期 / III 期中国有中心NCT03755739
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
China
年龄 18 Years – 不限
Second Affiliated Hospital of Guangzhou Medical University
正在招募I 期中国有中心NCT07106827
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
China
年龄 18 Years – 不限
West China Hospital
正在招募II 期中国有中心NCT06965231
Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial
China
年龄 18 Years – 不限
Fudan University
正在招募不适用中国有中心NCT07760012
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
China
年龄 18 Years – 75 Years
Peking University Third Hospital
正在招募不适用中国有中心NCT07584291
Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma
China
年龄 18 Years – 80 Years
Xijing Hospital
正在招募II 期中国有中心NCT07492680
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
United States、Belgium、Canada、China、France 等 12 国
年龄 18 Years – 不限
Bristol-Myers Squibb
正在招募I 期 / II 期中国有中心NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
United States、Australia、China、Taiwan
年龄 18 Years – 不限
DualityBio Inc.
正在招募I 期 / II 期中国有中心NCT06359860
A Study of ST-1898 for Unresectable or Metastatic Melanoma
China
年龄 18 Years – 不限
Beijing Scitech-Mq Pharmaceuticals Limited
正在招募III 期中国有中心NCT06008106
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
China
年龄 18 Years – 不限
Shanghai Kechow Pharma, Inc.
正在招募I 期 / II 期中国有中心NCT07099430
A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
China
年龄 18 Years – 不限
Nanjing Leads Biolabs Co.,Ltd
正在招募II 期中国有中心NCT04331093
Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma
China
年龄 18 Years – 75 Years
Di Wu